Gather Evidence Related to Your Case: With the help of your legal team, you will need to gather evidence related to your case
Follow the AAOS on Facebook, X, LinkedIn, and Instagram
Optimizing Endpoints for GLP-1 RA Clinical Trial Success Empowering Patient-Centric Research in Obesity, Diabetes, and Cardiovascular Health As GLP-1 receptor agonists (GLP-1 RAs) revolutionize the treatment landscape for obesity, diabetes, and related cardiovascular complications, Signant leads the way in capturing critical patient-reported outcomes (PROs) data
It activates the GLP-1 receptor, which in turn slows gastric emptying, inhibits the release of glucagon, and stimulates insulin production
Some people genetically produce lower levels of natural GLP hormones, meaning they do not sense when they are full, and end up binge eating, says Kim Dennis , a psychiatrist and CEO of SunCloud Health treatment center in Chicago